356 related articles for article (PubMed ID: 18430758)
1. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
[TBL] [Abstract][Full Text] [Related]
2. Current development status of small-molecule vascular disrupting agents.
Chaplin DJ; Horsman MR; Siemann DW
Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
[TBL] [Abstract][Full Text] [Related]
3. Vascular disrupting agents.
Pilat MJ; Lorusso PM
J Cell Biochem; 2006 Nov; 99(4):1021-39. PubMed ID: 16927308
[TBL] [Abstract][Full Text] [Related]
4. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
Horsman MR; Bohn AB; Busk M
Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery.
Cooney MM; van Heeckeren W; Bhakta S; Ortiz J; Remick SC
Nat Clin Pract Oncol; 2006 Dec; 3(12):682-92. PubMed ID: 17139319
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and definition of vascular-targeted therapies.
Siemann DW; Bibby MC; Dark GG; Dicker AP; Eskens FA; Horsman MR; Marmé D; Lorusso PM
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):416-20. PubMed ID: 15701823
[TBL] [Abstract][Full Text] [Related]
7. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and antiangiogenic therapy in endometriosis.
Becker CM; D'Amato RJ
Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
Morabito A; Sarmiento R; Bonginelli P; Gasparini G
Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
[TBL] [Abstract][Full Text] [Related]
10. Vascular damaging agents.
Patterson DM; Rustin GJ
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
Griffioen AW; Molema G
Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101
[TBL] [Abstract][Full Text] [Related]
12. Current strategies and future directions of antiangiogenic tumor therapy.
Zhang ZL; Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
[TBL] [Abstract][Full Text] [Related]
13. The first international conference on vascular targeting: meeting overview.
Thorpe PE; Chaplin DJ; Blakey DC
Cancer Res; 2003 Mar; 63(5):1144-7. PubMed ID: 12615734
[TBL] [Abstract][Full Text] [Related]
14. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and vascular targeting: relevance for hyperthermia.
Horsman MR
Int J Hyperthermia; 2008 Feb; 24(1):57-65. PubMed ID: 18214769
[TBL] [Abstract][Full Text] [Related]
16. Potential role of vascular targeted therapy to combat against tumor.
Chen B; Jin H; Wu K
Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis: an update and potential drug approaches (review).
Abdelrahim M; Konduri S; Basha R; Philip PA; Baker CH
Int J Oncol; 2010 Jan; 36(1):5-18. PubMed ID: 19956828
[TBL] [Abstract][Full Text] [Related]
18. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
19. The interaction of radiation therapy and antiangiogenic therapy.
O'Reilly MS
Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
[TBL] [Abstract][Full Text] [Related]
20. [Antivascular strategies--a new concept for diagnosis and therapy of head and neck cancer. A review].
Dellian M; Eichhorn ME; Strieth S
Laryngorhinootologie; 2002 Jul; 81(7):509-15. PubMed ID: 12173062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
